Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Advillin acts upstream of phospholipase C ϵ1 in steroid-resistant nephrotic syndrome
Jia Rao, … , Jose C. Martins, Friedhelm Hildebrandt
Jia Rao, … , Jose C. Martins, Friedhelm Hildebrandt
Published October 23, 2017
Citation Information: J Clin Invest. 2017;127(12):4257-4269. https://doi.org/10.1172/JCI94138.
View: Text | PDF
Research Article Nephrology Article has an altmetric score of 7

Advillin acts upstream of phospholipase C ϵ1 in steroid-resistant nephrotic syndrome

  • Text
  • PDF
Abstract

Steroid-resistant nephrotic syndrome (SRNS) is a frequent cause of chronic kidney disease. Here, we identified recessive mutations in the gene encoding the actin-binding protein advillin (AVIL) in 3 unrelated families with SRNS. While all AVIL mutations resulted in a marked loss of its actin-bundling ability, truncation of AVIL also disrupted colocalization with F-actin, thereby leading to impaired actin binding and severing. Additionally, AVIL colocalized and interacted with the phospholipase enzyme PLCE1 and with the ARP2/3 actin-modulating complex. Knockdown of AVIL in human podocytes reduced actin stress fibers at the cell periphery, prevented recruitment of PLCE1 to the ARP3-rich lamellipodia, blocked EGF-induced generation of diacylglycerol (DAG) by PLCE1, and attenuated the podocyte migration rate (PMR). These effects were reversed by overexpression of WT AVIL but not by overexpression of any of the 3 patient-derived AVIL mutants. The PMR was increased by overexpression of WT Avil or PLCE1, or by EGF stimulation; however, this increased PMR was ameliorated by inhibition of the ARP2/3 complex, indicating that ARP-dependent lamellipodia formation occurs downstream of AVIL and PLCE1 function. Together, these results delineate a comprehensive pathogenic axis of SRNS that integrates loss of AVIL function with alterations in the action of PLCE1, an established SRNS protein.

Authors

Jia Rao, Shazia Ashraf, Weizhen Tan, Amelie T. van der Ven, Heon Yung Gee, Daniela A. Braun, Krisztina Fehér, Sudeep P. George, Amin Esmaeilniakooshkghazi, Won-Il Choi, Tilman Jobst-Schwan, Ronen Schneider, Johanna Magdalena Schmidt, Eugen Widmeier, Jillian K. Warejko, Tobias Hermle, David Schapiro, Svjetlana Lovric, Shirlee Shril, Ankana Daga, Ahmet Nayir, Mohan Shenoy, Yincent Tse, Martin Bald, Udo Helmchen, Sevgi Mir, Afig Berdeli, Jameela A. Kari, Sherif El Desoky, Neveen A. Soliman, Arvind Bagga, Shrikant Mane, Mohamad A. Jairajpuri, Richard P. Lifton, Seema Khurana, Jose C. Martins, Friedhelm Hildebrandt

×

Figure 4

AVIL colocalizes with and interacts with PLCE1 and the ARP2/3 complex.

Options: View larger image (or click on image) Download as PowerPoint
AVIL colocalizes with and interacts with PLCE1 and the ARP2/3 complex.
(...
(A) Human podocytes transfected with a GFP-tagged, full-length (FL) mouse Avil construct were immunostained with mouse anti-paxillin (red), mouse anti-ARP3 (red), and rabbit anti-PLCE1 (red) antibodies, respectively. Note the colocalization of AVIL and ARP3 at podocyte lamellipodia (empty white arrowheads) and the colocalization of AVIL and PLCE1 at lamellipodia (solid white arrowheads). AVIL also overlapped with paxillin at FAs. Scale bars: 10 μm. Inset scale bars: 25 μm. (B) AVIL interacted with PLCE1 upon co-overexpression in HEK293T cells. GFP-tagged AVIL was co-overexpressed with Flag-tagged PLCE1 in HEK293T cells. Co-IP using Flag showed that GFP-tagged AVIL interacted with Flag-tagged PLCE1. (C and D) Upon co-overexpression in HEK293T cells, Myc-tagged ACTR2 (ARP2 complex) (C) and ACTR3 (ARP3 complex) (D) interacted with GFP-tagged AVIL. (E) Under EGF stimulation (100 ng/ml) in human cultured podocytes, PLCE1 (green) translocated to cell membrane ruffles, where it colocalized with ARP3 (red, solid white arrowheads). Cells depleted of AVIL by shRNA failed to recruit PLCE1 to the ARP-marked lamellipodia (empty white arrowheads) upon EGF stimulation. Scale bars: 10 μm. Inset scale bars: 25 μm. (F) Human podocytes were transfected with scrambled siRNA, siRNA-9, or siRNA-11 for AVIL. EGF stimulation increased the concentration of DAG in scrambled siRNA–treated control cells (black circles). siRNA-mediated knockdown of AVIL decreased active DAG levels (pink circles). The overexpression of WT Avil rescued this effect (green circles), while the 3 mutant clones (Arg135Gln, Leu425Met, and Phe656Valfs*7) from patients with SRNS did not (red circles). Individual data points were derived from 3 independent experiments and are displayed as the mean and SD. Statistical analysis was performed using a 2-tailed, 1-way ANOVA [F (7,16) = 92.09, P < 0.0001]. ***P < 0.0001, by Sidak’s multiple comparisons test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 6 X users
Referenced in 1 patents
On 1 Facebook pages
53 readers on Mendeley
See more details